AlphaCrest Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

AlphaCrest Capital Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-70,200	Closed	-$2.31M	–	1470
2021 Q3	$2.31M	Buy	+70,200	New	+$2.62M	0.12%	236
2021 Q2	–	Sell	-27,000	Closed	-$1.03M	–	1380
2021 Q1	$1.03M	Buy	27,000 +14,900	+123%	+$634K	0.06%	487
2020 Q4	$529K	Sell	12,100 -1,220	-9%	-$45.9K	0.04%	612
2020 Q3	$524K	Buy	+13,320	New	+$430K	0.06%	561
2019 Q4	–	Sell	-14,074	Closed	-$669K	–	1423
2019 Q3	$669K	Buy	14,074 +2,610	+23%	+$123K	0.04%	777
2019 Q2	$492K	Sell	11,464 -954	-8%	-$37K	0.04%	706
2019 Q1	$480K	Buy	+12,418	New	+$421K	0.07%	476

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

AlphaCrest Capital Management's CSII Position: Q4 2021 in Review

AlphaCrest Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2021, closing a stake of 70,200 shares — an estimated $2.31M sold.

AlphaCrest Capital Management first reported a position in CSII in Q1 2019 and held it in 7 quarters. The position peaked at $2.31M in Q3 2021. 167 funds tracked by Wall St. Rank hold CSII as of Q4 2021.

AlphaCrest Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q4 2021 after selling out during the quarter.
AlphaCrest Capital Management sold 70,200 Cardiovascular Systems, Inc. shares in Q4 2021, an estimated $2.31M.
AlphaCrest Capital Management first reported a position in Cardiovascular Systems, Inc. in Q1 2019 and held it in 7 quarters.
AlphaCrest Capital Management's Cardiovascular Systems, Inc. position peaked at $2.31M in Q3 2021.
167 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2021.

Based on AlphaCrest Capital Management's 13F filing for Q4 2021, filed 9 Feb 2022.